Philip Chennell

1.2k total citations · 1 hit paper
48 papers, 830 citations indexed

About

Philip Chennell is a scholar working on Biomedical Engineering, Polymers and Plastics and Occupational Therapy. According to data from OpenAlex, Philip Chennell has authored 48 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomedical Engineering, 9 papers in Polymers and Plastics and 8 papers in Occupational Therapy. Recurrent topics in Philip Chennell's work include Safe Handling of Antineoplastic Drugs (8 papers), Polymer Science and PVC (7 papers) and Ocular Infections and Treatments (6 papers). Philip Chennell is often cited by papers focused on Safe Handling of Antineoplastic Drugs (8 papers), Polymer Science and PVC (7 papers) and Ocular Infections and Treatments (6 papers). Philip Chennell collaborates with scholars based in France, Switzerland and Belgium. Philip Chennell's co-authors include Valérie Sautou, Nicolas Tokhadzé, Yoann Le Basle, A. Astier, Lise Bernard, Bruno Pereira, Daniel Bourdeaux, Bénédicte Mailhot, Céline Lambert and Géraldine Lamblin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Philip Chennell

42 papers receiving 800 citations

Hit Papers

Physicochemical Stability of Monoclonal Antibodies: A Review 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Chennell France 14 280 201 153 108 88 48 830
Ahmed Besheer Germany 21 454 1.6× 113 0.6× 258 1.7× 11 0.1× 35 0.4× 33 1.1k
Laura Sabatini Italy 21 150 0.5× 21 0.1× 74 0.5× 179 1.7× 56 0.6× 46 1.0k
Xiangbin Pan China 15 195 0.7× 60 0.3× 294 1.9× 99 0.9× 27 0.3× 79 1.4k
Marek Malý Czechia 22 374 1.3× 75 0.4× 73 0.5× 185 1.7× 340 3.9× 91 1.6k
Margareth Marques United States 8 157 0.6× 24 0.1× 175 1.1× 67 0.6× 27 0.3× 40 1.3k
Zhen Ding China 21 309 1.1× 111 0.6× 68 0.4× 68 0.6× 19 0.2× 89 1.6k
Mohan Shenoy India 17 217 0.8× 118 0.6× 74 0.5× 16 0.1× 109 1.2× 85 970
Ralph Santos‐Oliveira Brazil 21 252 0.9× 275 1.4× 461 3.0× 9 0.1× 34 0.4× 125 1.4k
Tianle Li China 16 188 0.7× 15 0.1× 66 0.4× 73 0.7× 82 0.9× 94 873
Ralph Santos‐Oliveira Brazil 19 239 0.9× 152 0.8× 296 1.9× 29 0.3× 27 0.3× 101 1.1k

Countries citing papers authored by Philip Chennell

Since Specialization
Citations

This map shows the geographic impact of Philip Chennell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Chennell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Chennell more than expected).

Fields of papers citing papers by Philip Chennell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Chennell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Chennell. The network helps show where Philip Chennell may publish in the future.

Co-authorship network of co-authors of Philip Chennell

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Chennell. A scholar is included among the top collaborators of Philip Chennell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Chennell. Philip Chennell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chennell, Philip, et al.. (2025). Physical stability of bevacizumab solutions for intravitreal injections: Influence of conditioning material and storage conditions. International Journal of Pharmaceutics. 674. 125453–125453.
2.
Érivan, Roger, et al.. (2025). Study of the release kinetics of dalbavancin from bone allografts. Journal of Materials Science Materials in Medicine. 36(1). 68–68.
3.
Basle, Yoann Le, et al.. (2024). Development and characterization of novel fast-dissolving pentobarbital suppositories for pediatric procedural sedation and comparison with lipophilic formulations. European Journal of Pharmaceutics and Biopharmaceutics. 204. 114532–114532.
4.
Devémy, Julien, Philip Chennell, Jérémy Pinguet, et al.. (2024). Leaching of plasticizers from PVC medical devices: A molecular interpretation of experimental migration data. Journal of Molecular Liquids. 396. 123965–123965. 8 indexed citations
5.
Lagarce, Frédéric, Isabelle Roland, Denis Brossard, et al.. (2024). Recommendations on training objectives and staff qualification for the manual preparation of capsules in pharmacy. SHILAP Revista de lepidopterología. 9(1). 1 indexed citations
6.
Sautou, Valérie, et al.. (2023). Long term physicochemical stability study of novel ophthalmic formulations combining ceftazidime and vancomycin with and without cyclodextrins. SHILAP Revista de lepidopterología. 8(1). 1 indexed citations
7.
Chennell, Philip, Bruno Pereira, R. Cueff, et al.. (2023). A proof of principle study using radiopharmaceuticals to quantify and localize container-content interactions in medical syringes. Scientific Reports. 13(1). 2721–2721.
8.
Beyssac, Eric, et al.. (2023). Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics. 15(3). 755–755. 2 indexed citations
9.
Sautou, Valérie, et al.. (2022). A Minireview on Brain Models Simulating Geometrical, Physical, and Biochemical Properties of the Human Brain. Frontiers in Bioengineering and Biotechnology. 10. 818201–818201. 5 indexed citations
10.
Balayssac, David, et al.. (2022). Lien ville-–hôpital et anticancéreux oraux : opinion des pharmaciens de l’Aveyron. Bulletin du Cancer. 109(6). 692–706. 4 indexed citations
12.
Chennell, Philip, et al.. (2022). Evaluation of color changes during stability studies using spectrophotometric chromaticity measurements versus visual examination. Scientific Reports. 12(1). 8959–8959. 19 indexed citations
13.
Bernard, Lise, Jérémy Pinguet, Damien Richard, et al.. (2020). Quantification of bis(2-ethylhexyl) phthalate released by medical devices during respiratory assistance and estimation of patient exposure. Chemosphere. 255. 126978–126978. 20 indexed citations
15.
Basle, Yoann Le, Philip Chennell, & Valérie Sautou. (2017). A Sorption Study between Ophthalmic Drugs and Multi Dose Eyedroppers in Simulated Use Conditions. SHILAP Revista de lepidopterología. 2(4). 6 indexed citations
16.
Chennell, Philip, et al.. (2017). Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions. European Journal of Pharmaceutical Sciences. 100. 230–237. 13 indexed citations
17.
Tokhadzé, Nicolas, Philip Chennell, Yoann Le Basle, & Valérie Sautou. (2017). Stability of infliximab solutions in different temperature and dilution conditions. Journal of Pharmaceutical and Biomedical Analysis. 150. 386–395. 23 indexed citations
18.
Chennell, Philip, et al.. (2016). Rubber Coring of Injectable Medication Vial Stoppers: An Evaluation of Causal Factors. SHILAP Revista de lepidopterología. 1(4). 3 indexed citations
19.
Bourdeaux, Daniel, et al.. (2015). Analysis of PVC plasticizers in medical devices and infused solutions by GC–MS. Journal of Pharmaceutical and Biomedical Analysis. 118. 206–213. 67 indexed citations
20.
Chennell, Philip, et al.. (2013). In vitro evaluation of TiO2 nanotubes as cefuroxime carriers on orthopaedic implants for the prevention of periprosthetic joint infections. International Journal of Pharmaceutics. 455(1-2). 298–305. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026